Ticker Details
PERRIGO COMPANY PLC Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.
IPO Date:	December 17, 1991
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$2.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.72 | 1.24%
Avg Daily Range (30 D):	$0.23 | 1.59%
Avg Daily Range (90 D):	$0.25 | 1.62%

Institutional Daily Volume
Avg Daily Volume:	1.07M
Avg Daily Volume (30 D):	1.77M
Avg Daily Volume (90 D):	2.42M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	17,687
Avg Institutional Trade:	$3.55M
Avg Institutional Trade (30 D):	$3.82M
Avg Institutional Trade (90 D):	$4.6M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$6.93M
Avg Closing Trade (30 D):	$5.31M
Avg Closing Trade (90 D):	$8.39M
Avg Closing Volume:	125.97K

News

Feb 18, 2026 @ 9:00 AM Scar Treatment Market Size is Expected to Reach US... Source: Sns Insider

Feb 6, 2026 @ 8:15 PM 3 Healthcare Stocks Paying the Highest Dividends o... Source: Thomas Niel

Feb 2, 2026 @ 3:30 PM Infant Nutrition Market Projected to Reach US$ 162... Source: Astute Analytica

Jan 21, 2026 @ 8:10 PM Perrigo Celebrates National Store Brand Month by S... Source: Prnewswire

Jan 16, 2026 @ 5:00 PM Bronstein, Gewirtz & Grossman LLC Urges Perrigo Co... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.37	$.05	$-.06
Diluted EPS	$-.37	$.05	$-.06
Revenue	$4.28B	$1.04B	$1.06B
Gross Profit	$1.52B	$377.1M	$362.9M
Net Income / Loss	$-51.8M	$7.5M	$-8.4M
Operating Income / Loss	$279.1M	$72.6M	$45.4M
Cost of Revenue	$2.76B	$666.2M	$693.4M
Net Cash Flow	$-1055.7M	$-20M	$7.8M
PE Ratio